About: The international EAN survey on neurological symptoms in patients with COVID‐19 infection

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The international EAN survey on neurological symptoms in patients with COVID‐19 infection Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	The international EAN survey on neurological symptoms in patients with COVID‐19 infection
Creator	Maia, L Moro, Elena Pisani, A Bassetti, C Beghi, E Bereczki, D Bianchi, E Bodini, B Campiglio, L Cavallieri, F Crean, M Sellner, J Helbok, R Jenkins, T Liberto, G Macerollo, A Moro, E Oreja-Guevara, C Ozturk, S Priori, A Rakusa, M Sauerbier, A Soffietti, R Taba, P Twardzik, A Von Oertzen, T Zedde, M
Source	Medline; PMC
abstract	BACKGROUND AND PURPOSE: Although the main clinical features of COVID‐19 infection are pulmonary, several associated neurological signs, symptoms and diseases are emerging. Incidence and characteristics of neurological complications are unclear. For this reason, the European Academy of Neurology (EAN) core COVID‐19 Task Force initiated a survey on neurological symptoms observed in patients with COVID‐19 infection. METHODS: A 17‐question on‐line survey was made available on the EAN website and distributed to EAN members and other worldwide physicians starting on April 9(th), 2020. RESULTS: By April 27(th,) 2020, proper data were collected from 2,343 responders (out of 4,199), of whom 82.0% were neurologists, mostly from Europe. Most responders (74.7%) consulted patients with COVID‐19 mainly in emergency rooms and in COVID‐19 units. The majority (67.0%) had evaluated fewer than 10 patients with neurological manifestations of COVID‐19 (neuro COVID‐19). The most frequently reported neurological findings were headache (61.9%), myalgia (50.4%), anosmia (49.2%), ageusia (39.8%), impaired consciousness (29.3%), and psychomotor agitation (26.7%). Encephalopathy and acute cerebrovascular disorders were reported at 21.0%. Neurological manifestations were generally interpreted as being possibly related to COVID‐19, they were most commonly recognized in patients with multiple general symptoms, and occurred at any time during infection. CONCLUSION: Neurologists are currently and actively involved in the management of neurological issues related to the COVID‐19 pandemic. This survey justifies setting up a prospective registry to better capture the prevalence of patients with neuro COVID‐19, neurological disease characteristics and the contribution of neurological manifestations to outcome.
has issue date	2020-06-17(xsd:dateTime)
bibo:doi	10.1111/ene.14407
bibo:pmid	32558002
has license	no-cc
sha1sum (hex)	5f2c4c9ffe3f7dd193d42a3651515e0e10ec703a
schema:url	https://doi.org/10.1111/ene.14407
resource representing a document's title	The international EAN survey on neurological symptoms in patients with COVID‐19 infection
has PubMed Central identifier	PMC7323212
has PubMed identifier	32558002
schema:publication	Eur J Neurol
resource representing a document's body	covid:5f2c4c9ffe3f7dd193d42a3651515e0e10ec703a#body_text
is schema:about of	named entity 'Although' named entity 'For' named entity 'PURPOSE' named entity 'patients' named entity 'infection' named entity 'initiated' named entity 'signs, symptoms' named entity 'COVID-19' named entity 'infection' named entity 'neurological symptoms' named entity 'stroke' named entity 'microglia' named entity 'general population' named entity 'neurological disease' named entity 'olfactory tract' named entity 'angiotensin II' named entity 'case series' named entity 'Portugal' named entity 'clinical features' named entity 'viral infection' named entity 'neurological complications' named entity 'immune-mediated' named entity 'neurologists' named entity 'dyspnoea' named entity 'early sign' named entity 'SARS-CoV-2' named entity 'toxic encephalopathy' named entity 'neurological diseases' named entity 'infection' named entity 'brain tissue' named entity 'medical specialty' named entity 'general population' named entity 'EAN' named entity 'neurologists' named entity 'meningitis' named entity 'COVID-19 infection' named entity 'encephalitis' named entity 'Clinical presentation' named entity 'preclinical models' named entity 'COVID-19 outbreak' named entity 'COVID-19' named entity 'COVID' named entity 'SARS-CoV-2' named entity 'fever' named entity 'neurological complications' named entity 'viral infection' named entity 'ageusia' named entity 'infection' named entity 'symptoms and signs' named entity 'Anosmia' named entity 'pyrexia' named entity 'primary physician' named entity 'ageusia' named entity 'anosmia' named entity 'pro-inflammatory'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software